Secreted proprotein convertase subtilisin/kexin type 9 reduces both hepatic and extrahepatic low-density lipoprotein receptors in vivo

Biochemical and Biophysical Research Communications
Robert J SchmidtGuoqing Cao

Abstract

Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a serine protease that is known to reduce hepatic low-density lipoprotein receptor (LDLR) levels and increase plasma LDL cholesterol. It is not clear, however, whether secreted PCSK9 degrades extrahepatic LDLRs. We present evidence that recombinant PCSK9, either injected intravenously into or expressed in the liver of C57BL/6 mice, significantly reduced LDLR levels in multiple extrahepatic tissues. During the initial characterization, we found that injected human recombinant PCSK9 at 30 microg/mouse had a half-life of 15 min in serum in mice. Hepatic LDLR levels were reduced within 30min and the degradation of hepatic LDLR reached the maximum 2h after the initial protein injection. Endocytosis of PCSK9 in liver occurred within 5min of protein injection and internalized PCSK9 was only barely detectable within 1h. When extrahepatic LDLRs were examined by Western blotting analysis, we found significant reductions of LDLRs in multiple extrahepatic tissues including lung, adipose and kidney along with the more dramatic reduction of LDLRs in liver. These studies were further extended using adenoviral expression of human PCSK9 in C57BL/6 mice to demonstrate that PCSK9 produced i...Continue Reading

References

Apr 4, 1986·Science·M S Brown, J L Goldstein
Sep 29, 1999·Proceedings of the National Academy of Sciences of the United States of America·M S Brown, J L Goldstein
Jan 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·Nabil G SeidahMichel Chretien
May 6, 2003·Nature Genetics·Marianne AbifadelCatherine Boileau
May 1, 2004·Proceedings of the National Academy of Sciences of the United States of America·Kara N Maxwell, Jan L Breslow
Apr 5, 2005·Proceedings of the National Academy of Sciences of the United States of America·Shirya RashidJay D Horton
Mar 24, 2006·The New England Journal of Medicine·Jonathan C CohenHelen H Hobbs
Nov 3, 2006·The Journal of Clinical Investigation·Thomas A LagaceJay D Horton
Jan 12, 2007·Trends in Biochemical Sciences·Jay D HortonHelen H Hobbs
Mar 14, 2007·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Nabil G Seidah, Annik Prat
Apr 17, 2007·Nature Structural & Molecular Biology·David CunninghamXiayang Qiu
May 12, 2007·The Journal of Biological Chemistry·Timothy S FisherAyesha Sitlani
Jun 1, 2007·The Journal of Biological Chemistry·Markey C McNuttJay D Horton
Jul 5, 2007·The Biochemical Journal·Jun LiJennifer L Harris
Jul 25, 2007·Biochemical and Biophysical Research Communications·Janice MayneTeik Chye Ooi
Nov 24, 2007·Journal of Lipid Research·Holly E CareskeyRobert J Konrad

❮ Previous
Next ❯

Citations

Sep 10, 2009·Journal of Lipid Research·Jason S TrouttRobert J Konrad
May 11, 2010·Journal of Lipid Research·Mali LiuCelina V Zerbinatti
Nov 21, 2008·Journal of Lipid Research·Jay D HortonHelen H Hobbs
Jan 24, 2014·Science Translational Medicine·Thomas J Urban, David B Goldstein
Oct 23, 2015·Clinical Pharmacology and Therapeutics·G P S Shantha, J G Robinson
Aug 2, 2008·Trends in Biochemical Sciences·Philippe CostetBertrand Cariou
Nov 26, 2009·Journal of Internal Medicine·S A MousaviT P Leren
Nov 3, 2009·Biochemical and Biophysical Research Communications·Cédric LanghiBertrand Cariou
May 15, 2015·European Heart Journal·Yuichi J Shimada, Christopher P Cannon
Sep 10, 2015·Journal of Clinical Lipidology·Hanny WassefMay Faraj
May 21, 2011·Atherosclerosis·Bertrand CariouPhilippe Costet
Jul 25, 2008·Atherosclerosis·Gilles LambertDerek E Piper
Sep 16, 2016·Omics : a Journal of Integrative Biology·Nyarai D SokoCollet Dandara
Sep 25, 2016·Archives of Medical Research·Shuo LiuJianhui Xie
Jan 14, 2017·International Urology and Nephrology·P PavlakouM Elisaf
Oct 1, 2014·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Dengfeng HanJing Lei
Apr 30, 2014·Journal of Lipid Research·Bomie HanKrista M Schroeder
Apr 6, 2013·Arteriosclerosis, Thrombosis, and Vascular Biology·Cédric Le MayPhilippe Costet
May 24, 2014·Circulation Research·Noam Zelcer, Marit Westerterp
Mar 27, 2018·Annals of Medicine·Najmeh AhangariAlireza Pasdar
Oct 28, 2018·Nature Reviews. Endocrinology·Robert M StoekenbroekG Kees Hovingh
Jan 6, 2011·Expert Opinion on Therapeutic Targets·Christopher J Duff, Nigel M Hooper

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.